The Technical Analyst
ZimVie Inc. [ZIMV]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
ZimVie Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
-1.59% $15.43
America/New_York / 19 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 417.90 mill |
| EPS: | -2.12 |
| P/E: | -7.28 |
| Earnings Date: | Apr 30, 2024 |
| SharesOutstanding: | 27.08 mill |
| Avg Daily Volume: | 0.379 mill |
| RATING 2024-04-19 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -7.28 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.03x |
| Company: PE -7.28 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-12.79 (-182.89%) $-28.22 |
| Date: 2024-04-19 |
| Expected Trading Range (DAY) |
|---|
|
$ 14.45 - 16.35 ( +/- 6.14%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-01 | Jamali Vafa | Buy | 21 331 | Common Stock |
| 2024-04-01 | Jamali Vafa | Sell | 9 333 | Common Stock |
| 2024-04-01 | Jamali Vafa | Sell | 21 331 | Restricted Stock Units |
| 2024-03-31 | Kuntz Richard | Buy | 764 | Deferred Share Units |
| 2024-03-31 | King David P | Buy | 2 438 | Deferred Share Units |
| INSIDER POWER |
|---|
| 39.90 |
| Last 99 transactions |
| Buy: 1 317 895 | Sell: 509 560 |
Forecast:
16:00 - $15.42
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $15.42
Forecast 2: 16:00 - $15.42
Forecast 3: 16:00 - $15.42
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $15.43 (-1.59% ) |
| Volume | 0.172 mill |
| Avg. Vol. | 0.379 mill |
| % of Avg. Vol | 45.47 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ZIMV
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:34 | sell | $19.37 | N/A | Active |
|---|
ZIMV
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
Last 10 Buy Signals
Latest Press Releases
2024-04-01 08:00:00 - Press Release
Zimvie Announces Closing Of Sale Of Spine Business
Completion of sale to an affiliate of h.i.g. capital for $375 million establishes pure-play dental business completion of sale to an affiliate of h.i.g. capital for $375 million establishes pure-play dental business
2024-03-27 08:00:00 - Press Release
Zimvie To Participate In The 23rd Annual Needham Virtual Healthcare Conference
Westminster, colo., march 27, 2024 (globe newswire) -- zimvie inc. (nasdaq: zimv), a global life sciences leader in the dental and spine markets, today announced management will participate in the upcoming 23rd annual needham virtual healthcare conference. management will be presenting on wednesday, april 10th, 2024 at 3:00 p.m. eastern time / 12:00 p.m. pacific time.
2024-02-21 17:00:00 - Press Release
Zimvie To Report Fourth Quarter And Full-year 2023 Financial Results On February 28, 2024
Westminster, colo., feb. 21, 2024 (globe newswire) -- zimvie inc. (nasdaq: zimv), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full-year 2023 after market close on wednesday, february 28, 2024. company management will host a corresponding conference call beginning at 4:30 p.m. eastern time.
2024-02-07 16:05:00 - Press Release
Zimvie Announces Launch Of Next-generation Tsx® Implant In Japan
Newest implant innovation is designed for immediacy and peri-implant health newest implant innovation is designed for immediacy and peri-implant health
2023-10-31 08:00:00 - Press Release
Zimvie Announces First U.s. Surgery With The 4.5mm Mobi-c® Cervical Disc
Westminster, colo., oct. 31, 2023 (globe newswire) -- zimvie inc. (nasdaq: zimv), a global life sciences leader in the dental and spine markets, today announced that the first patient in the united states has received the newly approved 4.5mm mobi-c® cervical disc. introduced in france in 2004, mobi-c became the first cervical disc approved for one and two levels by the fda in 2013. the smaller 4.5mm height mobi-c implants, available in seven footprints to match patient anatomy, were approved by the fda in august of this year.
Latest News
2024-02-28 21:52:03 - Seeking Alpha
ZimVie Inc. (ZIMV) Q4 2023 Earnings Call Transcript
2024-02-21 17:00:00 - GlobeNewsWire
ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
WESTMINSTER, Colo., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full-year 2023 after market close on Wednesday, February 28, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
2023-12-26 19:21:02 - Seeking Alpha
ZimVie: Focusing On Higher Growth Dental Business (Rating Upgrade)
ZimVie's stock has doubled since reporting Q3 earnings, causing investors to wonder about the company's future. The company's Q3 revenues declined less than expected and the company raised full-year guidance. More importantly, ZimVie's decision to sell its spine business for $375 million jettisons an underperforming segment while solving a debt overhang.
2023-11-01 21:57:13 - Seeking Alpha
ZimVie Inc. (ZIMV) Q3 2023 Earnings Call Transcript
ZimVie Inc. (NASDAQ:ZIMV ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Vafa Jamali - President and Chief Executive Officer Richard Heppenstall - Chief Financial Officer Conference Call Participants Lilly Wyttenbach - JPMorgan Matt Miksic - Barclays Operator Good day, and thank you for standing by. Welcome to the ZimVie Third Quarter 2023 Financial Results Conference Call.
2023-10-18 19:32:50 - InvestorPlace
Brace for Impact: 7 Stocks to Sell Amid Rising Troubles
While it's an uncomfortable topic, every investor must face the prospect of stocks to sell. Like it or not, market success doesn't just come down to picking winners.
2023-10-12 13:32:41 - Zacks Investment Research
ZimVie (ZIMV) Progresses in Dental Space With Biotivity Launch
ZimVie's (ZIMV) Biotivity A/C Plus Membrane is a barrier membrane that contains an array of growth factors.
2023-08-10 10:00:21 - Zacks Investment Research
Why Fast-paced Mover ZimVie Inc. (ZIMV) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, ZimVie Inc. (ZIMV) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
2023-08-06 02:21:01 - Seeking Alpha
ZimVie Inc. (ZIMV) Q2 2023 Earnings Call Transcript
ZimVie Inc. (NASDAQ:ZIMV ) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Vafa Jamali - President and Chief Executive Officer Rich Heppenstall - Chief Financial Officer Conference Call Participants Robert Marcus - JPMorgan Chase & Co. Matt Miksic - Barclays Operator Good afternoon, and welcome to ZimVie's Second Quarter 2023 Earnings Conference Call. Currently, all participants are in listen-only mode.
2023-07-18 09:49:10 - Zacks Investment Research
ZimVie Inc. (ZIMV) Stock Jumps 20.6%: Will It Continue to Soar?
ZimVie Inc. (ZIMV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
2023-07-12 16:05:00 - GlobeNewsWire
ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023
WESTMINSTER, Colo., July 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the second quarter 2023 after market close on Wednesday, August 2, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.